Table 1.

Exclusion of 6 FA patient cell lines from known complementation groups: cell fusion experiments



Complementation group
Cell line
A
B
C
D1
E
F
G
EUFA592   75 ± 13.2   > 100 ± 0   30 ± 13.9   24.5 ± 4.9   76 ± 8.5   60 ± 0   90 ± 14.1  
  N = 3   N = 3   N = 6   N = 2   N = 2   N = 2   N = 2  
EUFA816   23 ± 2.6   23 ± 10.0   21 ± 16.2   34 ± 2.1   18 ± 0   Failed   100 ± 0  
  N = 3   N = 3   N = 3   N = 2   N = 1   (4 ×)   N = 2  
EUFA961   57 ± 12.7   37 ± 7.1   ND   73 ± 11.1   > 100 ± 0   ND   ND  
  N = 4   N = 2    N = 6   N = 4    
EUFA696   69 ± 10.6   83 ± 5.2   28 ± 0   40 ± 0   75 ± 23.0   Failed   58 ± 25.0  
  N = 4   N = 3   N = 2   N = 1   N = 3   (18 ×)   N = 4  
EUFA543   68 ± 8.7   44 ± 11.5   Failed   83 ± 24.7   68 ± 27.5   Failed   33 ± 6.4  
  N = 4   N = 3   (4 ×)   N = 2   N = 3   (8 ×)   N = 3  
AG656   55 ± 12.9   58 ± 15.8   47 ± 11.5   > 100 ± 0   > 100 ± 0   36 ± 19.8   39 ± 27.6  

 
N = 3
 
N = 3
 
N = 3
 
N = 2
 
N = 2
 
N = 2
 
N = 3
 


Complementation group
Cell line
A
B
C
D1
E
F
G
EUFA592   75 ± 13.2   > 100 ± 0   30 ± 13.9   24.5 ± 4.9   76 ± 8.5   60 ± 0   90 ± 14.1  
  N = 3   N = 3   N = 6   N = 2   N = 2   N = 2   N = 2  
EUFA816   23 ± 2.6   23 ± 10.0   21 ± 16.2   34 ± 2.1   18 ± 0   Failed   100 ± 0  
  N = 3   N = 3   N = 3   N = 2   N = 1   (4 ×)   N = 2  
EUFA961   57 ± 12.7   37 ± 7.1   ND   73 ± 11.1   > 100 ± 0   ND   ND  
  N = 4   N = 2    N = 6   N = 4    
EUFA696   69 ± 10.6   83 ± 5.2   28 ± 0   40 ± 0   75 ± 23.0   Failed   58 ± 25.0  
  N = 4   N = 3   N = 2   N = 1   N = 3   (18 ×)   N = 4  
EUFA543   68 ± 8.7   44 ± 11.5   Failed   83 ± 24.7   68 ± 27.5   Failed   33 ± 6.4  
  N = 4   N = 3   (4 ×)   N = 2   N = 3   (8 ×)   N = 3  
AG656   55 ± 12.9   58 ± 15.8   47 ± 11.5   > 100 ± 0   > 100 ± 0   36 ± 19.8   39 ± 27.6  

 
N = 3
 
N = 3
 
N = 3
 
N = 2
 
N = 2
 
N = 2
 
N = 3
 

Data on hybrids generated from the indicated cell lines and reference cell lines A-G are summarized. Numbers are IC50 values for MMC ± SD. Data do not include group D2, since these fusions had exceedingly low success rates; a retroviral vector expressing FANCD2 was used instead (Table 2).

ND indicates no data available.

Close Modal

or Create an Account

Close Modal
Close Modal